[go: up one dir, main page]

Guo et al., 2010 - Google Patents

Efficient conjugation doxorubicin to bacterial magnetic nanoparticles via a triplex hands coupling reagent

Guo et al., 2010

Document ID
10365608163673710427
Author
Guo L
Huang J
Zheng L
Publication year
Publication venue
Journal of Nanoscience and Nanotechnology

External Links

Snippet

By using a novel triplex “hand” coupling reagent, tris-succinimidyl aminotriacetate (TSAT), doxorubicin loading efficiency of BMP can be greatly enhanced in comparison with that of dual functional linkers. The drug loading ratio of doxorubicin-coupled bacterial magnetic …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Yu et al. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation
Sun et al. Preparation and anti‐tumor efficiency evaluation of doxorubicin‐loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense
AU703042B2 (en) Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
Zhu et al. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes
Soares et al. Boron nitride nanotubes radiolabeled with 99mTc: Preparation, physicochemical characterization, biodistribution study, and scintigraphic imaging in Swiss mice
KR20010024836A (en) Magnetically responsive composition
CN107802840B (en) Tumor microenvironment-responsive nanoparticles based on peptide dendrimer modified fluorescent carbon dots and preparation method thereof
CN104840977B (en) A kind of preparation method of magnetic fluorescence composite Nano pharmaceutical carrier
Sha et al. Manganese-doped gold core mesoporous silica particles as a nanoplatform for dual-modality imaging and chemo-chemodynamic combination osteosarcoma therapy
EP3092012B1 (en) Magnetic nanoparticles functionalized with cathecol, production and use thereof
Zhu et al. Cobalt nanowire-based multifunctional platform for targeted chemo-photothermal synergistic cancer therapy
Wu et al. Remotely controlled drug release based on iron oxide nanoparticles for specific therapy of cancer
KR20180070558A (en) Particles comprising at least one ferrimagnetic or ferromagnetic iron oxide nanoparticle in combination with at least one compound for medical or cosmetic purposes
Kumar et al. In vitro and bioimaging studies of mesoporous silica nanocomposites encapsulated iron-oxide and loaded doxorubicin drug (DOX/IO@ Silica) as magnetically guided drug delivery system
AU772755B2 (en) Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents
Wang et al. Preparation and drug releasing property of magnetic chitosan-5-fluorouracil nano-particles
Guo et al. Bacterial magnetic nanoparticles as drug carriers
Zhang et al. pH responsive and zwitterionic micelle for enhanced cellular uptake and antitumor performance
Gupta et al. Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage
Zhang et al. Low density lipoprotein peptide-conjugated gold nanorods for combating gastric cancer
Cui et al. Dual enzyme-like performances of PLGA grafted maghemite nanocrystals and their synergistic chemo/chemodynamic treatment for human lung adenocarcinoma A549 cells
Guo et al. Efficient conjugation doxorubicin to bacterial magnetic nanoparticles via a triplex hands coupling reagent
De Cuyper et al. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate
Zhao et al. Thermochemotherapy mediated by novel solar-planet structured magnetic nanocomposites for glioma treatment
Guo et al. Control generating of bacterial magnetic nanoparticle–doxorubicin conjugates bypoly-L-glutamic acid surface modification